Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Second Generation Antipsychotic-Induced Type 2 Diabetes: A Role for the Muscarinic M3 Receptor
Katrina Weston‐Green, Xu‐Feng Huang, Chao Deng
CNS Drugs (2013) Vol. 27, Iss. 12, pp. 1069-1080
Closed Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder
Christoph U. Correll, Johan Detraux, Jan De Lepeleire, et al.
World Psychiatry (2015) Vol. 14, Iss. 2, pp. 119-136
Open Access | Times Cited: 706
The Inositol Trisphosphate/Calcium Signaling Pathway in Health and Disease
Michael J. Berridge
Physiological Reviews (2016) Vol. 96, Iss. 4, pp. 1261-1296
Open Access | Times Cited: 626
Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine
Kanako Kimura, Hidetsugu Asada, Asuka Inoue, et al.
Nature Structural & Molecular Biology (2019) Vol. 26, Iss. 2, pp. 121-128
Closed Access | Times Cited: 171
Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences
Marco Carli, Shivakumar Kolachalam, Biancamaria Longoni, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 238-238
Open Access | Times Cited: 158
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia
Ashleigh L. Osborne, Nadia Solowij, Katrina Weston‐Green
Neuroscience & Biobehavioral Reviews (2016) Vol. 72, pp. 310-324
Open Access | Times Cited: 144
Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model
Ashleigh L. Osborne, Nadia Solowij, Ilijana Babic, et al.
Neuropsychopharmacology (2017) Vol. 42, Iss. 7, pp. 1447-1457
Open Access | Times Cited: 130
Impact of Psychotropic Medication Effects on Obesity and the Metabolic Syndrome in People With Serious Mental Illness
Victor Mazereel, Johan Detraux, Davy Vancampfort, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 129
Endogenous and Antipsychotic-Related Risks for Diabetes Mellitus in Young People With Schizophrenia: A Danish Population-Based Cohort Study
Anto P. Rajkumar, Henriette Thisted Horsdal, Theresa Wimberley, et al.
American Journal of Psychiatry (2017) Vol. 174, Iss. 7, pp. 686-694
Open Access | Times Cited: 114
Weight Gain and Metabolic Changes During Treatment with Antipsychotics and Antidepressants
Hubertus Himmerich, Juliane Minkwitz, Kenneth C. Kirkby
Endocrine Metabolic & Immune Disorders - Drug Targets (2015) Vol. 15, Iss. 4, pp. 252-260
Closed Access | Times Cited: 110
Clozapine’s multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia
Andrea de Bartolomeis, Licia Vellucci, Annarita Barone, et al.
Pharmacology & Therapeutics (2022) Vol. 236, pp. 108236-108236
Open Access | Times Cited: 49
Diabetes and Mental Health
David J. Robinson, Kimberley Hanson, Akshay Jain, et al.
Canadian Journal of Diabetes (2023) Vol. 47, Iss. 4, pp. 308-344
Open Access | Times Cited: 36
Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes
Jiezhong Chen, Xu‐Feng Huang, Renfu Shao, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 77
The risk of new-onset diabetes in antidepressant users – A systematic review and meta-analysis
Virginio Salvi, Ilaria Grua, Giancarlo Cerveri, et al.
PLoS ONE (2017) Vol. 12, Iss. 7, pp. e0182088-e0182088
Open Access | Times Cited: 73
Antipsychotic-induced changes in blood levels of leptin in schizophrenia: a meta-analysis.
Stéphane Potvin, Simon Zhornitsky, Émmanuel Stip
PubMed (2015) Vol. 60, Iss. 3 Suppl 2, pp. S26-34
Closed Access | Times Cited: 70
Schizophrenia and type 2 diabetes mellitus
Vasiliki Mamakou, Anastasia Thanopoulou, Fragiskos Gonidakis, et al.
Psychiatriki (2018) Vol. 29, Iss. 1, pp. 64-73
Open Access | Times Cited: 66
Bipolar disorder and diabetes mellitus: evidence for disease-modifying effects and treatment implications
Ellen F. Charles, Christophe G Lambert, Berit Kerner
International Journal of Bipolar Disorders (2016) Vol. 4, Iss. 1
Open Access | Times Cited: 57
Cannabidiol improves behavioural and neurochemical deficits in adult female offspring of the maternal immune activation (poly I:C) model of neurodevelopmental disorders
Ashleigh L. Osborne, Nadia Solowij, Ilijana Babic, et al.
Brain Behavior and Immunity (2019) Vol. 81, pp. 574-587
Closed Access | Times Cited: 47
Efficacy and Safety of a Combination of Olanzapine and Samidorphan in Adult Patients With an Acute Exacerbation of Schizophrenia
Steven G. Potkin, Jelena Kunovac, Bernard L. Silverman, et al.
The Journal of Clinical Psychiatry (2020) Vol. 81, Iss. 2
Open Access | Times Cited: 46
Risk factors, prevention and treatment of weight gain associated with the use of antidepressants and antipsychotics: a state-of-the-art clinical review
Marco Solmi, Alessandro Miola, Federico Capone, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 10, pp. 1249-1269
Closed Access | Times Cited: 5
Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats
Xuemei Liu, Zhixiang Wu, Jiamei Lian, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 46
Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics
Samantha Álvarez-Herrera, Raúl Escamilla, Óscar Medina‐Contreras, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 36
When therapeutic drugs lead to diabetes
Bruno Fève, André Scheen
Diabetologia (2022) Vol. 65, Iss. 5, pp. 751-762
Open Access | Times Cited: 22
Comorbidity Between Severe Mental Disorders and Metabolic Disease
Е. Г. Старостина
(2025), pp. 181-202
Closed Access
Systematic review and meta-analysis of weight gain and metabolic changes in children and adolescents using second-generation antipsychotics
Suzana Figueiredo Collares, Antônio Pereira Magalhães, Talita D. Martins, et al.
Pharmacology Biochemistry and Behavior (2025), pp. 174012-174012
Closed Access
The dosage-dependent effects of cevimeline in preventing clozapine-induced dyslipidaemia in female rats
Jiamei Lian, Bo Pan, Chao Deng
Pharmacology Biochemistry and Behavior (2025), pp. 174017-174017
Open Access
Page 1 - Next Page

Scroll to top